LONDON, 24-6-2014 — /EuropaWire/ — Maris Interiors LLP have now completed an office design & relocation project for BOSE Ltd.
Bose UK Ltd is part of the global Bose group of companies based in Massachusetts, USA. Started in 1964 by Amar G. Bose, today, Bose has operations in the United States, Europe, Canada, Australia, Asia and South America.
Bose have appointed Maris to undertake the office relocation of their UK headquarters.
Previously Bose had two offices in Gillingham. Our office fit-out project involved the relocation and consolidation those offices into one new landmark, waterside building in Chatham.
The new office at Quayside, Chatham Maritime emcompasses 20,000 sq over four floors.
Maris’ scope of work included: full concept design, detail design and cost consultancy. We developed an office design scheme which incorporated open-plan workspace together with a small element of cellularisation.
The office also includes a number of training rooms, a management suite and a large staff breakout/diner.
Notes:
www.bose.co.uk
Quayside, Chatham Maritime, Chatham, Kent ME4
Maris Interiors LLP is the UK’s leading specialist in workplace consultancy, workplace optimisation, office design, office refurbishment, office fit-out and office relocation. Maris design and create world class working environments for occupiers throughout the UK and continental Europe. The Maris team of experts has extensive and in-depth knowledge of how good office design and fit-out can substantially improve business performance, save vast amounts of money and help retain and attract key people.
This news article may be reused subject to Maris Interiors LLP being credited and acknowledged as the source
WOULD YOU LIKE TO LEARN ABOUT OUR OUTSTANDING CLIENT SERVICES?
Talk To Robin Dey Our Refurbishment Specialist
020 7902 1884
Email Me
###
(IN BRIEF) Eurex, on April 29, 2024, introduced a new Green Bond Basket within its…
(IN BRIEF) Last Friday, NMB Bank Plc celebrated the listing of its dual-currency sustainability bond,…
(IN BRIEF) CapMan Nordic Infrastructure II fund has reached its final closing at over €375…
(IN BRIEF) AstraZeneca and Daiichi Sankyo's Enhertu, a HER2-directed antibody drug conjugate (ADC), has demonstrated…
(IN BRIEF) AstraZeneca's Truqap, in combination with Faslodex, has received a positive recommendation from the…
(IN BRIEF) Ørsted, a global leader in renewable energy, is divesting its French onshore operations…